Chemed Corp (CHE) Social Stream
CHEMED CORP (CHE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CHEMED CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 3 | $609 | $580 | $596.333 | $574.5 | 3.8% |
| 2022-01-19 | 3 | $610 | $580 | $599.666 | $574.5 | 4.38% |
| 2022-05-10 | 3 | $609 | $575 | $588 | $574.5 | 2.35% |
| 2022-07-28 | 3 | $580 | $575 | $577.5 | $574.5 | 0.52% |
| 2022-11-01 | 3 | $580 | $541 | $565.333 | $574.5 | -1.6% |
| 2023-02-08 | 3 | $580 | $545 | $566.666 | $574.5 | -1.36% |
| 2023-02-24 | 3 | $590 | $545 | $571.666 | $574.5 | -0.49% |
| 2023-03-14 | 3 | $590 | $580 | $585.666 | $574.5 | 1.94% |
| 2023-04-27 | 3 | $610 | $580 | $592.333 | $574.5 | 3.1% |
| 2023-04-28 | 3 | $610 | $587 | $602.333 | $574.5 | 4.84% |
| 2023-06-06 | 3 | $610 | $610 | $610 | $574.5 | 6.18% |
| 2023-07-27 | 3 | $610 | $590 | $603.333 | $574.5 | 5.02% |
| 2023-07-31 | 3 | $610 | $576 | $592 | $574.5 | 3.05% |
| 2023-10-26 | 3 | $640 | $576 | $602 | $574.5 | 4.79% |
| 2023-11-05 | 3 | $640 | $590 | $611.333 | $574.5 | 6.41% |
| 2023-12-15 | 3 | $680 | $590 | $624.666 | $574.5 | 8.73% |
The Trend in the Analyst Price Target
Over the past 46 weeks, CHE's average price target has gone up $58.
CHE reports an average of 10.76% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 3 | 580 | 545 | 566.666 | 498.94 | 13.57% |
| 2023-03-14 | 3 | 590 | 580 | 585.666 | 516.00 | 13.5% |
| 2023-04-28 | 3 | 610 | 587 | 602.333 | 551.25 | 9.27% |
| 2023-07-27 | 3 | 610 | 590 | 603.333 | 520.74 | 15.86% |
| 2023-10-26 | 3 | 640 | 576 | 602.000 | 554.24 | 8.62% |
CHE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 2 | 1 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 15 months, CHE's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CHE has a greater average analyst price target than 1679.35% of all US stocks.
- CHEMED CORP's variance in analysts' estimates is lower than 31.85% of stocks in the mid market cap category.
- In the context of Healthcare stocks, CHEMED CORP's number of analysts covering the stock is higher than 81.82% of them.
- In the context of Healthcare stocks, CHEMED CORP's upside potential (average analyst target price relative to current price) is greater than 290.89% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to CHEMED CORP are SEM, MD, and TOI.
View All Top Stocks by Price Target
Is CHE a Buy, Hold or Sell? See the POWR Ratings now!